Auxier Asset Management’s Pfizer PFE Stock Holding History

Auxier Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.73M	Buy	61,759 +850	+1%	+$22.6K	0.25%	87
2025 Q4	$1.52M	Sell	60,909 -3,830	-6%	-$96.6K	0.21%	93
2025 Q3	$1.65M	Sell	64,739 -600	-0.9%	-$14.8K	0.23%	87
2025 Q2	$1.58M	Buy	65,339 +281	+0.4%	+$6.55K	0.23%	84
2025 Q1	$1.65M	Sell	65,058 -470	-0.7%	-$12.3K	0.25%	83
2024 Q4	$1.74M	Sell	65,528 -2,725	-4%	-$73.9K	0.27%	83
2024 Q3	$1.98M	Sell	68,253 -525	-0.8%	-$15.3K	0.29%	80
2024 Q2	$1.92M	Buy	68,778 +243	+0.4%	+$6.69K	0.3%	77
2024 Q1	$1.9M	Sell	68,535 -2,995	-4%	-$83.1K	0.29%	81
2023 Q4	$2.06M	Sell	71,530 -570	-0.8%	-$17.2K	0.33%	75
2023 Q3	$2.39M	Sell	72,100 -250	-0.3%	-$8.84K	0.41%	68
2023 Q2	$2.65M	Buy	72,350 +4,664	+7%	+$182K	0.44%	66
2023 Q1	$2.76M	Buy	67,686 +670	+1%	+$28.9K	0.48%	63
2022 Q4	$3.43M	Sell	67,016 -850	-1%	-$40.8K	0.59%	47
2022 Q3	$2.97M	Sell	67,866 -1,562	-2%	-$75.9K	0.57%	50
2022 Q2	$3.64M	Sell	69,428 -790	-1%	-$40.3K	0.65%	45
2022 Q1	$3.63M	Sell	70,218 -4,955	-7%	-$257K	0.58%	52
2021 Q4	$4.44M	Sell	75,173 -598	-0.8%	-$29.6K	0.69%	47
2021 Q3	$3.26M	Sell	75,771 -650	-0.9%	-$28.8K	0.55%	54
2021 Q2	$2.99M	Sell	76,421 -2,930	-4%	-$114K	0.5%	60
2021 Q1	$2.88M	Sell	79,351 -5,675	-7%	-$201K	0.49%	60
2020 Q4	$3.13M	Sell	85,026 -4,697	-5%	-$172K	0.58%	58
2020 Q3	$3.12M	Buy	89,723 +478	+0.5%	+$16.8K	0.65%	50
2020 Q2	$2.77M	Buy	89,245 +12,021	+16%	+$408K	0.61%	52
2020 Q1	$2.39M	Sell	77,224 -946	-1%	-$32.2K	0.6%	47
2019 Q4	$2.91M	Sell	78,170 -881	-1%	-$31.4K	0.54%	54
2019 Q3	$2.69M	Buy	79,051 +22	+0%	+$800	0.54%	57
2019 Q2	$3.25M	Buy	79,029 +1,871	+2%	+$74.3K	0.65%	50
2019 Q1	$3.11M	Buy	77,158 +1,186	+2%	+$47.5K	0.64%	49
2018 Q4	$3.15M	Sell	75,972 -4,006	-5%	-$166K	0.7%	46
2018 Q3	$3.34M	Sell	79,978 -316	-0.4%	-$12.2K	0.63%	48
2018 Q2	$2.76M	Sell	80,294 -2,213	-3%	-$75.6K	0.55%	59
2018 Q1	$2.78M	Sell	82,507 -356	-0.4%	-$12.2K	0.56%	59
2017 Q4	$2.85M	Sell	82,863 -2,583	-3%	-$88.1K	0.55%	57
2017 Q3	$2.89M	Sell	85,446 -4,848	-5%	-$156K	0.59%	56
2017 Q2	$2.88M	Buy	90,294 +843	+0.9%	+$26.6K	0.59%	54
2017 Q1	$2.9M	Sell	89,451 -659	-0.7%	-$20.8K	0.61%	56
2016 Q4	$2.78M	Buy	90,110 +504	+0.6%	+$15.4K	0.6%	56
2016 Q3	$2.88M	Sell	89,606 -932	-1%	-$31.2K	0.64%	52
2016 Q2	$3.02M	Hold	90,538	–	–	0.69%	51
2016 Q1	$2.55M	Sell	90,538 -342	-0.4%	-$9.77K	0.6%	53
2015 Q4	$2.78M	Sell	90,880 -103	-0.1%	-$3.24K	0.63%	53
2015 Q3	$2.71M	Hold	90,983	–	–	0.63%	53
2015 Q2	$2.89M	Sell	90,983 -13,288	-13%	-$433K	0.6%	54
2015 Q1	$3.44M	Sell	104,271 -48,220	-32%	-$1.53M	0.7%	50
2014 Q4	$4.51M	Sell	152,491 -1,001	-0.7%	-$28.7K	0.9%	43
2014 Q3	$4.31M	Sell	153,492 -29	-0%	-$814	0.9%	45
2014 Q2	$4.32M	Sell	153,521 -238	-0.2%	-$6.78K	0.88%	42
2014 Q1	$4.69M	Sell	153,759 -14,168	-8%	-$422K	1%	38
2013 Q4	$4.88M	Sell	167,927 -7,958	-5%	-$232K	1.03%	36
2013 Q3	$4.79M	Hold	175,885	–	–	1.11%	34
2013 Q2	$4.67M	Buy	+175,885	New	+$4.86M	1.13%	34

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Auxier Asset Management's PFE Position: Q1 2026 in Review

Auxier Asset Management increased its Pfizer (PFE) stake by 1.4% in Q1 2026, buying an estimated $22.6K and bringing the position to 61,759 shares worth $1.73M. The position accounts for 0.25% of the portfolio, ranked #87.

Auxier Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.88M in Q4 2013. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Auxier Asset Management held 61,759 shares of Pfizer worth $1.73M as of Q1 2026.
Auxier Asset Management bought 850 Pfizer shares in Q1 2026, an estimated $22.6K.
Pfizer made up 0.25% of Auxier Asset Management's portfolio in Q1 2026, its #87 holding.
Auxier Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Auxier Asset Management's Pfizer position peaked at $4.88M in Q4 2013.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Auxier Asset Management's 13F filing for Q1 2026, filed 14 May 2026.